Inducible gene expression in mammalian cells and transgenic mice

Current Opinion in Biotechnology

Volumn 8, Issue 5, 1997, Pages 608-616

  Saez, Enrique ^a   No, David ^a   West, Andrew ^a   Evans, Ronald M ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; ECDYSONE; FK 506 BINDING PROTEIN; IMMUNOPHILIN; MIFEPRISTONE; STEROID HORMONE; TACROLIMUS; TETRACYCLINE;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; BIOMEDICINE; DIMERIZATION; GENE ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; GENETIC TRANSCRIPTION; MAMMAL CELL; MOUSE; NONHUMAN; OPERON; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

ANIMALIA; MAMMALIA; MUS MUSCULUS;

EID: 0030681310     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(97)80037-7     Document Type: Article

References (54)

1. Gatz C, Quail PH: Tn-10-encoded Tet repressor can regulate an operator-containing plant promoter. Proc Natl Acad Sci USA 1988, 85:1394-1937.
2. Gatz C, Kaiser A, Wendenburg R: Regulation of a modified CaMV 35S promoter by the Tn-10-encoded Tet repressor in transgenic tobacco. Mol Gen Genet 1991, 227:229-237.
3. Gossen M, Bujard H: Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992, 89:5547-5551.
4. Wimmel A, Lucibello FC, Sewing A, Adolph S, Muller R: Inducible acceleration of G1 progression through tetracycline-regulated expression of human cyclin E. Oncogene 1994, 9:995-997.
5. Früh K, Gossen M, Wang K, Bujard H, Peterson PA, Yang Y: Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex. EMBO J 1994, 13:3236-3244.
6. Yu H, Rabson AB, Kaul M, Ron Y, Dougherty JP: Inducible human immunodeficiency virus type I packaging cell lines. J Virol 1996, 70:4530-4537.
7. Wu S-Y, Chiang C-M: Establishment of stable cell lines expressing potentially toxic proteins by tetracycline-regulated and epitope-tagging methods. Bio-Techniques 1996, 21:718-725.
8. Hennighausen L, Wall RJ, Tillmann U, Li M, Furth PA: Conditional gene expression in secretory tissues and skin of transgenic mice using the MMTV-LTR and the tetracycline responsive system. J Cell Biochem 1995, 59:463-472.
9. Schockett P, Difilippantonio M, Hellman N, Schatz DG: A modified tetracycline-regulated system provides autoregulatory inducible gene expression in cultured cells and transgenic mice. Proc Natl Acad Sci USA 1995, 92:6522-6526.
10. Bohl D, Naffakh N, Heard JM: Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts. Nat Med 1997, 3:299-305. This study presents a stringent test of the reverse tetracycline transactivator system in a setting relevant to gene therapy. Retroviruses were used to introduce the reverse tetracycline transactivator system into myoblasts. Production of Epo could be controlled by doxycycline in mice implemented with these cells.
11. Howe JR, Skryabin BV, Belcher SM, Zerillo CA, Schmauss C: The responsiveness of a tetracycline-sensitive expression system differs in different cell lines. J Biol Chem 1995, 23:14168-14174.
12. Schokett PE, Schatz DG: Diverse strategies for tetracycline-regulated inducible gene expression. Proc Natl Acad Sci USA 1996, 93:5173-5176.
13. Furth PA, St Onge L, Boger H, Gruss P, Gossen M, Kistner A, Bujard H, Hennighausen L: Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 1994, 91:9302-9306.
14. Passman RS, Fishman GI: Regulated expression of foreign genes in vivo after germline transfer. J Clin Invest 1994, 94:2421-2425.
15. Efrat S, Fusco-DeMane D, Lemberg H, Al Emran O, Wang X: Conditional transformation of a pancreatic β-cell line derived from transgenic mice expressing a tetracycline-regulated oncongene. Proc Natl Acad Sci USA 1995, 92:3576-3580
16. Ewald D, Li M, Efrat S, Auer G, Wall RJ, Furth PA, Hennighausen L: Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science 1996, 273:1384-1386.
17. Mayford M, Bach ME, Huang YY, Wang L, Hawkins RD, Kandel ER: Control of memory formation through regulated expression of a CaMKII transgene. Science 1996, 274:1678-1683. This study constitutes the clearest demonstration to date of the utility of the tetracycline transactivation system in transgenic mice. Brain-specific expression of a dominant CaMKII mutant induces a behavioral phenotype that can be reversed by administration of doxycycline.
18. Kistner A, Gossen M, Zimmerman F, Jerecic J, Ullmer C, Lubbert H, Bujard H: Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 1996, 93:10933-10938. The authors descride the first application of the reverse tetracycline transactivation system, see Gossen et al. 1995 [25], to transgenic mice. It also presents additional work with ubiquitous and tissue-specific tetracycline transactivation transgenics.
19. Hoffmann A, Villalba M, Journot L, Spengler D: A novel tetracycline-dependent expression vector with low basal expression and potent regulatory properties in various mammalian cells. Nucleic Acids Res 1997, 25:1078-1079.
20. Yoshida Y, Hamada H: Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal. Biochem Biophys Res Commun 1997, 230:426-430.
21. Iida A, Chen ST, Friedman T, Yee JK: Inducible gene expression by retrovirus-mediated transfer of a modified tetracycline-regulated system. J Virol 1996, 70:6054-6059.
22. Bohl D, Serguerra C, LeGall S, Naffakh N, Heard JM: Regulation of the systemic delivery of therapeutic proteins from engineered tissues. Keystone Symposia on Molecular and Cellular Biology of Gene Therapy: 1997 April; Snowbird, Utah. Silverthorne, Colorado: Keystone Symposia Organisation; 1997.
23. Ackland-Berglund CE, Leib DA: Efficacy of tetracycline-controlled gene expression is influenced by cell type. BioTechniques 1995, 18:196-200.
24. Cohlan SQ: Tetracycline staining of teeth. Teratology 1977, 15:127-130.
25. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H: Transcriptional activation by tetracyclines in mammalian cells. Science 1995, 268:1766-1769.
26. Schultze N, Burki Y, Lang Y, Certa U, Bluethmann H: Efficient control of gene expression by single step integration of the tetracycline system in transgenic mice. Nat Biotechnol 1996, 14:499-503. This study combines the regulation and expression units of the tetracycline transactivator system onto a single vector (Combi-tTA), facilitating the establishment of tetracycline-dependent gene regulation in stable cells and transgenic mice.
27. Riond JL, Riviere JE: Pharmacology and toxicology of doxycycline. Vet Human Toxicol 1988, 5:431-443.
28. Chrast-Balz J, Van Huijsduijnen RH: Bi-directional gene switching with the tetracycline repressor and a novel tetracycline antagonist Nucleic Acids Res 1996, 24:2900-2904. Isolation of a tetracycline antagonist that should prove useful to enhance the kinetics of gene switching in tetracycline repressor protein-based systems. Its mechanism of action is briefly explored.
29. Kapunisk-Uner JE, Sande MA, Chambers HFS: Tetracyclines, chloramphenicol, erythromycin, and miscellaneous antibacterial agents. In Goodman and Gilman's, The Pharmacological Basis of Therapeutics, edn 9. Edited by Hardman JG, Limbierd LE. New York: McGraw-Hill; 1996:1123-1153.
30. Kirchoff S, Koster M, Wirth M, Schaper F, Gossen M, Bujard H, Hauser H: Identification of mammalian cell clones exhibiting highly regulated expression from inducible promoters. Trends Genet 1995, 11:219-220.
31. Baron U, Freundlieb S, Gossen M, Bujard H: Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res 1995, 23:3605-3606.
32. Paulus W, Baur I, Boyce FM, Breakefield XO, Reeves SA: Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J Virol 1996, 70:62-67. Development of a single retroviral vector that allows delivery of the tetracycline transactivator system into whole populations. Due to the configuration of the components of the system within the vector, a very good degree of inducibility is seen in infected cells.
33. Hofmann A, Nolan GP, Blau HM: Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc Natl Acad Sci USA 1996, 93:5185-5190. A retrovirus combining the single-vector and the autoregulatory tetracycline transactivator strategies was developed and tested by infecting primary myoblasts. In an interesting experimental twist, populations exhibiting efficient tetracycline regulation were then selected by FACS analysis.
34. Wang Y, O'Malley BW, Tsai SY, O'Malley BW: A regulatory system for use in gene transfer. Proc Natl Acad Sci USA 1994, 91:8180-8184.
35. Delort JR Capecchi MR: TAXI/UAS: a molecular switch to control expression of genes in vivo. Hum Gene Ther 1996, 7:809-820.
36. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM: The nuclear receptor superfamily: the second decade. Cell 1995, 83:835-839.
37. Wang Y, DeMayo FJ, Tsai SY, O'Malley BW: Ligand-inducible and liver-specific target gene expression in transgenic mice. Nat Biotechnol 1997, 15:239-243. This paper applies work by Wang et al. 1994 [34] to animals. It describes the generation of transgenic mice expressing GLVP (a chimeric protein containing the VP16-transactivation domain, the GAL4 DNA-binding domain, and a mutated progesterone receptor ligand-binding domain), and the kinetics of RU486-mediated transgene regulation.
38. No D, Yao TP, Evans RM: Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci USA 1996, 93:3346-3351. This study describes the development of an inducible system based on the insect hormone ecdysone and its nuclear receptor. The optimization of the system for use in mammals is summarized.
39. Mangelsdorf DJ, Evans RM: The RXR heterodimers and orphan receptors. Cell 1995, 83:841-850.
40. Yao TP, Segraves WA, Oro AE, McKeown M, Evans RM: Drosophila ultraspiracle modulates ecdysone receptor function via heterodimer formation. Cell 1992, 71:63-72.
41. Christopherson KS, Mark MR, Bajaj V, Godowski PJ: Ecdysteroid-dependent regulation of genes in mammalian cells by a Drosophila ecdysone receptor and chimeric transactivators. Proc Natl Acad Sci USA 1992, 89:6314-6318.
42. No D: Ecdysone-inducible gene transcription in mammalian cells and transgenic mice [PhD Thesis]. San Diego: University of California at San Diego; 1996.
43. Lafont R, Girault JP, Kerb U: Excretion and metabolism of injected ecdysone in the white mouse. Biochem Pharmacol 1988, 37:1174-1177.
44. Spencer DM: Creating conditional mutations in mammals. Trends Genet 1996, 12:181-187. The bulk of this review provides an overview of the theoretical framework of chemical inducer dimerization technology, and a discussion of its applications in various scenarios.
45. Schreiber SL: Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 1991, 251:283-287.
46. Spencer DM, Wandless TJ, Schreiber SL, Crabtree GR: Controlling signal transduction with synthetic ligands. Science 1993, 262:1019-1024.
47. Belshaw PJ, Ho SN, Crabtree GR, Schreiber SL: Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins. Proc Natl Acad Sci USA 1996, 93:4604-4607. Creation and demonstration of the utility of the first synthetic heterodimerizing chemical inducer of dimerization. Showed that transcription in mammalian cells could be controlled by this heterodimerizer.
48. Rivera VM, Clackson T, Natesan S, Pollock R, Amara J, Keenan T, Magari SR, Phillips T, Courage NL, Cerasoli F et al.: A humanized system for pharmacologic control of gene expression. Nat Med 1996, 2:1028-1032. This work uses the natural heterodimerizing chemical inducer of dimerization rapamycin as the basis of an inducible system tailored for gene therapy applications. Its properties are explored in vitro, and in mice transplanted with cells stably expressing the components of this scheme.
49. Rivera V, Clackson T, Natesan S, Pollock R, Amara J, Keenan T, Rozamus L, Gilman M: Humanized system for pharmacologic control of gene expression. Keystone Symposia on Molecular and Cellular Biology of Gene Therapy: 1997 April; Snowbird, Utah. Silverthorne, Colorado: Keystone Symposia Organisation; 1997.
50. Pomerantz JL, Sharp PA, Pabo CO: Structure-based design of transcription factors. Science 1995, 267:93-96.
51. Belshaw PJ, Schoepfer JG, Liu KQ, Morrison KL, Schreiber SL: Rational design of orthogonal receptor-ligand combinations. Angew Chem Int Ed 1995, 34:2129-2132.
52. Liberles SD, Diver ST, Austin DJ, Schreiber SL: Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen. Proc Natl Acad Sci USA 1997, 94:7825-7830. This paper describes the synthesis of nontoxic rapamycin derivatives, employing a mammalian three-hybrid-based assay to discover mutant forms of FRAP that can interact with these safer analogs of rapamycin. These novel receptor-ligand complexes are used to control gene expression and signal transduction.
53. Gilman M: Imparting small-molecule control to gene and cell therapies. Keystone Symposia on Molecular and Cellular Biology of Gene Therapy: 1997 April; Snowbird, Utah. Silverthorne, Colorado: Keystone Symposia Organisation; 1997.
54. Ho SN, Biggar SR, Spencer DM, Schreiber SL, Crabtree GR: Dimeric ligands define a role for transcriptional activation domains in reinitiation. Nature 1996, 382:822-826. Interesting application of CID technology that makes use of the monomeric forms to speed up disruption of CID-immunophilin complexes. It also contains useful information regarding the kinetics of these interactions.